"If we do our jobs right, and you come back a year from now, this place is going to be a buzzing hive" -- Vertex Executive ...
Goldman Sachs said it reiterated Buy ratings on OneStream ( NASDAQ: OS ), Vertex ( NASDAQ: VERX) and Workiva ( NYSE: WK) ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
6h
Zacks.com on MSNVertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowVertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 ...
Vertex Flare is an online crypto trading platform designed using the latest technologies like artificial intelligence and ...
1d
Zacks.com on MSNVertex to Report Q4 Earnings: What's in Store for the Stock?Vertex, Inc. VERX is scheduled to report fourth-quarter 2024 results before market open on Feb. 27. Find the latest EPS ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.82% to $480.33 Thursday, on what proved to be an all-around grim trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results